Raising funds to advance high-impact mitochondrial research with applications across rare disease, neurodegeneration, and healthspan
A Media Snippet accompanying this announcement is available by clicking on this link.
ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Countdown For A Cure (CFAC) hosted its third annual Evening of Energy gala on February 7th at The St. Regis Atlanta, raising more than $1 million to advance mitochondrial research focused on cellular energy, the foundation of human health.
Hosted by Dr. Taz Bhatia, MD, nationally recognized integrative physician and founder of hol+, the evening brought together leaders across science, medicine, wellness, philanthropy, and culture to highlight the growing relevance of mitochondrial science in chronic illness, aging, and rare disease.
During the program, CFAC presented its highest honor, the Countdown For A Cure Award, to Douglas C. Wallace, PhD, Director of the Center for Mitochondrial & Epigenomic Medicine at Children’s Hospital of Philadelphia. Widely regarded as the father of mitochondrial medicine, Dr. Wallace was recognized for pioneering discoveries that established the role of mitochondria in human health, disease, and aging.
The 2026 Powerhouse Award was presented to Sonya Knebel, 2022 European Long Drive Champion and 2022 World Long Drive Bronze Medalist, honoring her leadership and advocacy following her experience with mitochondrial dysfunction.
The evening also featured remarks from Natalie Yivgi-Ohana, PhD, Founder and CEO of Minovia Therapeutics and 2025 CFAC grant recipient. Through its 2025 grant, CFAC is specifically supporting mitochondrial biomarker development, advancing tools to measure cellular function, track disease progression, and assess therapeutic response with greater precision. This work is critical to accelerating clinical translation and evaluating next-generation mitochondrial therapies.
The program blended science and storytelling, with a live performance by Izabela Rose and an after-party led by Grammy Award-winning producer DJ Babey Drew.
The 2026 Evening of Energy was made possible through the support of sponsors, including InPrime Legal and MoveDocs. “In science, Mitzi and Jeff are solving for the root cause,” said Jonathan Page, Founder of InPrime Legal. “They are building the foundation for the future of health.”
Funds raised will support CFAC’s expanding research pipeline and education initiatives, with additional 2026 grant announcements planned this spring.
“Disease moves quickly. To truly change lives, we have to move faster,” said Co-Founders Mitzi and Jeff Solomon. “Our third annual Evening of Energy reflects a powerful truth: when a community unites around bold science, progress accelerates. We are thankful for every partner and supporter helping advance mitochondrial research. But this is only the beginning. Together, we must continue to move with the speed and scale this work requires and deserves.”
The next Evening of Energy gala will take place on January 30, 2027, at The St. Regis Atlanta. Sponsorship opportunities are now available, and sponsors who commit before April 1st will receive enhanced recognition and access to an exclusive Founders experience.
For more information about Countdown For A Cure, sponsorship opportunities, or ways to get involved, visit www.CountdownForACure.org or email Info@CountdownForACure.org.
About Countdown For A Cure
Countdown For A Cure is the only nonprofit dedicated to accelerating broad mitochondrial science and medicine. The organization funds innovative research, elevates awareness of mitochondrial dysfunction as a critically overlooked driver of disease, and works to bring mitochondrial health out of the shadows and into everyday conversations about vitality, resilience, and longevity. Guided by the belief that Energy Is Everything, Countdown For A Cure is building a movement to transform preventive care and improve healthspan for today and for generations to come.
About the Evening of Energy Gala
The Evening of Energy is Countdown For A Cure’s signature annual fundraising gala, convening leaders across science, medicine, biotechnology, philanthropy, and wellness to advance mitochondrial research. The event highlights groundbreaking science, personal stories, and cross-sector partnerships centered on the role of cellular energy in human health. Proceeds support research, education, and collaboration to accelerate discoveries with broad impact.
The next Evening of Energy will take place on January 30, 2027. Sponsorship opportunities are available; commitments prior to April 1st will receive enhanced recognition and access to an exclusive Founders experience. For more information, visit www.CountdownForACure.org or email Info@CountdownForACure.org.
For more information, visit www.CountdownForACure.org
Follow CFAC on Instagram, Facebook, LinkedIn, X and YouTube
Contact:
Mitzi Solomon, Founder and President
Mitzi@CountdownForACure.org | +1 (917) 715-2381
-
三靶点激动剂UBT251中国II期临床研究:24周平均减重高达19.7%UBT251 是一款 GLP-1/GIP /GCG三靶点受体激动剂(三激动剂),由联邦生物与诺和诺德联合开发 在一项针对中国超重或肥胖患者的安慰剂对照 II 期临床研究中,用药 24 周2026-02-25
-
兰洋科技单相微流道液冷板产品取得关键性突破,系统布局跨产业技术赋能近日,兰洋研发团队根据实际芯片散热需求,采用传统铜金属材料和创新的微流道技术,在单相微流道液冷板技术产品上取得关键突破,并已成功实现该技术的商业化落地与规2026-02-25
-
第120届就要“玩大的”! CSF文化会联手国风IP「玲珑夏意」,共启产业融合新范式!第120届中国文化用品商品交易会(简称CSF文化会)已与现象级国风美学IP「玲珑夏意」达成全面战略合作! 「玲珑夏意」IP形象 2026年6月26日,CSF文化2026-02-25
-
同长城,共心安——长城人寿2026新春祝福广告亮相北京金融街购物中心春启新程,福暖万家。在2026马年新春到来之际,长城人寿以科技为媒、以祝福为桥,将品牌温度与新春喜悦融入视觉盛宴,倾力打造的2026新春祝福广告正式亮相北京金融街2026-02-25
-
君实生物与德琪医药达成战略合作,共同开展JS207(PD-1VEGF双抗)与ATG-037(CD73口服小分子抑制剂)联合用药研究上海2026年2月25日 美通社 -- 北京时间2026年2月25日,君实生物(1877.HK,688180.SH)宣布与德琪医药(6996.HK)达成战略合作,双方将共同探索君实生物自主研发的JS207(抗PD-1VEG2026-02-25
-
AMD股价暴跌17%创近9年之最,苏姿丰紧急回应:AI增速远超想象
-
慧启赣疆 聚势共赢丨慧友酒店集团江西品鉴会书写区域文旅融合新篇
-
电影《一秒》定档:2026年,活在这一秒
-
西藏斜视患儿寒假进京手术成功,千里护航点亮视觉未来
-
年度盛典|卓兴半导体2025年度总结表彰暨 2026 年迎新晚会
-
科技赋能 生态协同,登途集团车辆资产管理运营模式助推行业提质增效
-
公元地暖构建“产品+施工+服务”全维保障网,兑现50年温暖承诺
-
VCI Global 投资组合公司 Reveillon Group 与 NOWWA Coffee 达成战略合作,共同开拓马来西亚市场
-
易事特回应光伏逆变器国抽问题:完成全流程整改,产品均达国标要求
-
Agencia Comercial拟斥逾1.2亿美元跨界布局AI基础设施

